{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T12:52:49Z","timestamp":1774270369012,"version":"3.50.1"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Artif Intell"],"DOI":"10.1007\/s44163-025-00330-9","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T13:05:00Z","timestamp":1748178300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling the artificial intelligence role in drug discovery and pharmaceutical product design: an opportunity and challenges"],"prefix":"10.1007","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1748-2743","authenticated-orcid":false,"given":"Bhakti Sudha","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-3290","authenticated-orcid":false,"given":"Sumit","family":"Durgapal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-2830","authenticated-orcid":false,"given":"Prashant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1959-6337","authenticated-orcid":false,"given":"Gauree","family":"Kukreti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8261-293X","authenticated-orcid":false,"given":"Anjali","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9114-7080","authenticated-orcid":false,"given":"Girish","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-6552","authenticated-orcid":false,"given":"Manish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"330_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","volume":"26","author":"D Paul","year":"2021","unstructured":"Paul D, et al. Artificial intelligence in drug discovery and development. Drug Discov Today. 2021;26:80\u201393.","journal-title":"Drug Discov Today"},{"key":"330_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108702","volume":"178","author":"AD Gholap","year":"2024","unstructured":"Gholap AD, et al. Advances in artificial intelligence for drug delivery and development: a comprehensive review. Comput Biol Med. 2024;178: 108702.","journal-title":"Comput Biol Med"},{"key":"330_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1049\/ip-its:20060014","volume":"153","author":"JC Miles","year":"2006","unstructured":"Miles JC, Walker AJ. The potential application of artificial intelligence in transport. IEE Proc Intell Transp Syst. 2006;153:183.","journal-title":"IEE Proc Intell Transp Syst"},{"key":"330_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12032-022-01711-1","volume":"39","author":"S Quazi","year":"2022","unstructured":"Quazi S. Artificial intelligence and machine learning in precision and genomic medicine. Med Oncol. 2022;39:120.","journal-title":"Med Oncol"},{"key":"330_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/0113892029269523231101051455","volume":"24","author":"SK Ahuja","year":"2023","unstructured":"Ahuja SK, Shrimankar DD, Durge AR. A study and analysis of disease identification using genomic sequenceprocessing models: an empirical review. Curr Genomics. 2023;24:207\u201335.","journal-title":"Curr Genomics"},{"key":"330_CR6","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s11030-021-10225-3","volume":"25","author":"JM Vaz","year":"2021","unstructured":"Vaz JM, Balaji S. Convolutional neural networks (CNNs): concepts and applications in pharmacogenomics. Mol Divers. 2021;25:1569\u201384.","journal-title":"Mol Divers"},{"key":"330_CR7","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.csbj.2020.06.017","volume":"18","author":"L Koumakis","year":"2020","unstructured":"Koumakis L. Deep learning models in genomics; are we there yet? Comput Struct Biotechnol J. 2020;18:1466\u201373.","journal-title":"Comput Struct Biotechnol J"},{"key":"330_CR8","doi-asserted-by":"publisher","first-page":"ooac043","DOI":"10.1093\/jamiaopen\/ooac043","volume":"5","author":"R Bhatnagar","year":"2022","unstructured":"Bhatnagar R, Sardar S, Beheshti M, Podichetty JT. How can natural language processing help model informed drug development?: a review. JAMIA Open. 2022;5:ooac043.","journal-title":"JAMIA Open"},{"key":"330_CR9","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1021\/acs.jcim.3c00543","volume":"63","author":"L Wei","year":"2023","unstructured":"Wei L, et al. Hit identification driven by combining artificial intelligence and computational chemistry methods: a PI5P4K-\u03b2 case study. J Chem Inf Model. 2023;63:5341\u201355.","journal-title":"J Chem Inf Model"},{"key":"330_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105740","volume":"220","author":"PP Parvatikar","year":"2023","unstructured":"Parvatikar PP, et al. Artificial intelligence: machine learning approach for screening large database and drug discovery. Antiviral Res. 2023;220: 105740.","journal-title":"Antiviral Res"},{"key":"330_CR11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44359","author":"S Singh","year":"2023","unstructured":"Singh S, Kumar R, Payra S, Singh SK. Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.44359.","journal-title":"Cureus"},{"key":"330_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12859-019-3135-4","volume":"20","author":"S Kwon","year":"2019","unstructured":"Kwon S, Bae H, Jo J, Yoon S. Comprehensive ensemble in QSAR prediction for drug discovery. BMC Bioinform. 2019;20:521.","journal-title":"BMC Bioinform"},{"key":"330_CR13","doi-asserted-by":"publisher","first-page":"11488","DOI":"10.3390\/ijms241411488","volume":"24","author":"SK Niazi","year":"2023","unstructured":"Niazi SK, Mariam Z. Recent advances in machine-learning-based chemoinformatics: a comprehensive review. Int J Mol Sci. 2023;24:11488.","journal-title":"Int J Mol Sci"},{"key":"330_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13321-022-00623-6","volume":"14","author":"M Abbasi","year":"2022","unstructured":"Abbasi M, et al. Designing optimized drug candidates with generative adversarial network. J Cheminform. 2022;14:40.","journal-title":"J Cheminform"},{"key":"330_CR15","volume":"20","author":"I Asiamah","year":"2023","unstructured":"Asiamah I, Obiri SA, Tamekloe W, Armah FA, Borquaye LS. Applications of molecular docking in natural products-based drug discovery. Sci Afr. 2023;20: e01593.","journal-title":"Sci Afr"},{"key":"330_CR16","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"PC Agu","year":"2023","unstructured":"Agu PC, et al. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep. 2023;13:13398.","journal-title":"Sci Rep"},{"key":"330_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1021\/acs.jcim.2c01191","volume":"63","author":"YA Ivanenkov","year":"2023","unstructured":"Ivanenkov YA, et al. Chemistry42: an AI-driven platform for molecular design and optimization. J Chem Inf Model. 2023;63:695\u2013701.","journal-title":"J Chem Inf Model"},{"key":"330_CR18","doi-asserted-by":"publisher","first-page":"1331062","DOI":"10.3389\/fphar.2024.1331062","volume":"15","author":"A Gangwal","year":"2024","unstructured":"Gangwal A, et al. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities. Front Pharmacol. 2024;15:1331062.","journal-title":"Front Pharmacol"},{"key":"330_CR19","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3390\/pharmaceutics15071916","volume":"15","author":"LK Vora","year":"2023","unstructured":"Vora LK, et al. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15:1916.","journal-title":"Pharmaceutics"},{"key":"330_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2472630320956931","volume":"26","author":"MBMA Rashid","year":"2021","unstructured":"Rashid MBMA. Artificial intelligence effecting a paradigm shift in drug development. SLAS Technol. 2021;26:3\u201315.","journal-title":"SLAS Technol"},{"key":"330_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.tips.2019.05.005","volume":"40","author":"S Harrer","year":"2019","unstructured":"Harrer S, Shah P, Antony B, Hu J. Artificial intelligence for clinical trial design. Trends Pharmacol Sci. 2019;40:577\u201391.","journal-title":"Trends Pharmacol Sci"},{"key":"330_CR22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.drudis.2021.11.023","volume":"27","author":"RSK Vijayan","year":"2022","unstructured":"Vijayan RSK, Kihlberg J, Cross JB, Poongavanam V. Enhancing preclinical drug discovery with artificial intelligence. Drug Discov Today. 2022;27:967\u201384.","journal-title":"Drug Discov Today"},{"key":"330_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2023.100011","volume":"1","author":"S Yang","year":"2023","unstructured":"Yang S, Kar S. Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity. Artif Intell Chem. 2023;1: 100011.","journal-title":"Artif Intell Chem"},{"key":"330_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.fmre.2024.04.021","author":"AU Rehman","year":"2024","unstructured":"Rehman AU, et al. Role of artificial intelligence in revolutionizing drug discovery. Fundam Res. 2024. https:\/\/doi.org\/10.1016\/j.fmre.2024.04.021.","journal-title":"Fundam Res."},{"key":"330_CR25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45255","author":"A Alanazi","year":"2023","unstructured":"Alanazi A. Clinicians\u2019 views on using artificial intelligence in healthcare: opportunities, challenges, and beyond. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.45255.","journal-title":"Cureus"},{"key":"330_CR26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47486","author":"KS Vidhya","year":"2023","unstructured":"Vidhya KS, Sultana A, Naveen M, Rangareddy H. Artificial Intelligence\u2019s impact on drug discovery and development from bench to bedside. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.47486.","journal-title":"Cureus"},{"key":"330_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.addr.2019.05.001","volume":"151\u2013152","author":"P Hassanzadeh","year":"2019","unstructured":"Hassanzadeh P, Atyabi F, Dinarvand R. The significance of artificial intelligence in drug delivery system design. Adv Drug Deliv Rev. 2019;151\u2013152:169\u201390.","journal-title":"Adv Drug Deliv Rev"},{"key":"330_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s43094-024-00625-1","volume":"10","author":"KA Ali","year":"2024","unstructured":"Ali KA, et al. Influence of artificial intelligence in modern pharmaceutical formulation and drug development. Future J Pharm Sci. 2024;10:53.","journal-title":"Future J Pharm Sci"},{"key":"330_CR29","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.3390\/pharmaceutics14112257","volume":"14","author":"J Jiang","year":"2022","unstructured":"Jiang J, Ma X, Ouyang D, Williams RO. Emerging Artificial Intelligence (AI) technologies used in the development of solid dosage forms. Pharmaceutics. 2022;14:2257.","journal-title":"Pharmaceutics"},{"key":"330_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/ddc3010009","volume":"3","author":"R Dhudum","year":"2024","unstructured":"Dhudum R, Ganeshpurkar A, Pawar A. Revolutionizing drug discovery: a comprehensive review of AI applications. Drugs Drug Candidates. 2024;3:148\u201371.","journal-title":"Drugs Drug Candidates"},{"key":"330_CR31","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1007\/s10462-022-10306-1","volume":"56","author":"H Askr","year":"2023","unstructured":"Askr H, et al. Deep learning in drug discovery: an integrative review and future challenges. Artif Intell Rev. 2023;56:5975\u20136037.","journal-title":"Artif Intell Rev"},{"key":"330_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/13696998.2024.2315864","volume":"27","author":"A Abou Hajal","year":"2024","unstructured":"Abou Hajal A, Al Meslamani AZ. Insights into artificial intelligence utilisation in drug discovery. J Med Econ. 2024;27:304\u20138.","journal-title":"J Med Econ"},{"key":"330_CR33","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3390\/ijms24032026","volume":"24","author":"C Sarkar","year":"2023","unstructured":"Sarkar C, et al. Artificial intelligence and machine learning technology driven modern drug discovery and development. Int J Mol Sci. 2023;24:2026.","journal-title":"Int J Mol Sci"},{"key":"330_CR34","doi-asserted-by":"publisher","first-page":"1700153","DOI":"10.1002\/minf.201700153","volume":"37","author":"D Merk","year":"2018","unstructured":"Merk D, Friedrich L, Grisoni F, Schneider GD. De Novo design of bioactive small molecules by artificial intelligence. Mol Inform. 2018;37:1700153.","journal-title":"Mol Inform"},{"key":"330_CR35","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2022.v15i4.43890","author":"NV Kalayil","year":"2022","unstructured":"Kalayil NV, D\u2019Souza SS, Khan SY, Paul P. Artificial intelligence in pharmacy drug design. Asian J Pharm Clin Res. 2022. https:\/\/doi.org\/10.22159\/ajpcr.2022.v15i4.43890.","journal-title":"Asian J Pharm Clin Res"},{"key":"330_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00165","author":"G Baronzio","year":"2015","unstructured":"Baronzio G, Parmar G, Baronzio M. Overview of methods for overcoming hindrance to drug delivery to tumors, with special attention to tumor interstitial fluid. Front Oncol. 2015. https:\/\/doi.org\/10.3389\/fonc.2015.00165.","journal-title":"Front Oncol"},{"key":"330_CR37","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1021\/acs.jcim.5b00073","volume":"55","author":"NC Firth","year":"2015","unstructured":"Firth NC, Atrash B, Brown N, Blagg J. MOARF, an integrated workflow for multiobjective optimization: implementation, synthesis, and biological evaluation. J Chem Inf Model. 2015;55:1169\u201380.","journal-title":"J Chem Inf Model"},{"key":"330_CR38","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.drudis.2017.08.010","volume":"22","author":"L Zhang","year":"2017","unstructured":"Zhang L, Tan J, Han D, Zhu H. From machine learning to deep learning: progress in machine intelligence for rational drug discovery. Drug Discov Today. 2017;22:1680\u20135.","journal-title":"Drug Discov Today"},{"key":"330_CR39","doi-asserted-by":"publisher","first-page":"14814","DOI":"10.1039\/C4RA15478A","volume":"5","author":"N Jain Pancholi","year":"2015","unstructured":"Jain Pancholi N, Gupta S, Sapre N, Sapre NS. In silico de novo design of novel NNRTIs: a bio-molecular modelling approach. RSC Adv. 2015;5:14814\u201327.","journal-title":"RSC Adv"},{"key":"330_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10822-014-9827-y","volume":"29","author":"Y Wang","year":"2015","unstructured":"Wang Y, et al. A comparative study of family-specific protein\u2013ligand complex affinity prediction based on random forest approach. J Comput Aided Mol Des. 2015;29:349\u201360.","journal-title":"J Comput Aided Mol Des"},{"key":"330_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/08839519508945474","volume":"9","author":"RD King","year":"1995","unstructured":"King RD, Hirst JD, Sternberg MJE. Comparison of artificial intelligence methods for modeling pharmaceutical QSARS. Appl Artif Intell. 1995;9:213\u201333.","journal-title":"Appl Artif Intell"},{"key":"330_CR42","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/17460441.2019.1621284","volume":"14","author":"\u00d3 \u00c1lvarez-Machancoses","year":"2019","unstructured":"\u00c1lvarez-Machancoses \u00d3, Fern\u00e1ndez-Mart\u00ednez JL. Using artificial intelligence methods to speed up drug discovery. Expert Opin Drug Discov. 2019;14:769\u201377.","journal-title":"Expert Opin Drug Discov"},{"key":"330_CR43","unstructured":"Guo M, Kalra G, Wilson W, Peng Y, Augsburger LL. Hard gelatin capsule formulation development."},{"key":"330_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0168-3659(00)00248-0","volume":"68","author":"K Takayama","year":"2000","unstructured":"Takayama K, et al. Formula optimization of theophylline controlled-release tablet based on artificial neural networks. J Controlled Release. 2000;68:175\u201386.","journal-title":"J Controlled Release"},{"key":"330_CR45","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.drudis.2018.11.018","volume":"24","author":"CH Mehta","year":"2019","unstructured":"Mehta CH, Narayan R, Nayak UY. Computational modeling for formulation design. Drug Discov Today. 2019;24:781\u20138.","journal-title":"Drug Discov Today"},{"key":"330_CR46","unstructured":"Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Study | Sumitomo Pharma. https:\/\/www.sumitomo-pharma.com\/news\/20200130.html."},{"key":"330_CR47","unstructured":"Nature, R. C. by S. Preliminary phase 2a readout for a novel drug discovered and designed using generative AI sets a major milestone in AI-powered drug discovery. Research Communities by Springer Nature. 2024. https:\/\/communities.springernature.com\/posts\/preliminary-phase-2a-readout-for-a-novel-drug-discovered-and-designed-using-generative-ai-sets-a-major-milestone-in-ai-powered-drug-discovery."},{"key":"330_CR48","doi-asserted-by":"publisher","first-page":"9344","DOI":"10.3390\/app14209344","volume":"14","author":"VV Kleandrova","year":"2024","unstructured":"Kleandrova VV, Cordeiro MND, Speck-Planche A. Perturbation theory machine learning model for phenotypic early antineoplastic drug discovery: design of virtual anti-lung-cancer agents. Appl Sci. 2024;14:9344.","journal-title":"Appl Sci"},{"key":"330_CR49","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2174\/1568026621666210119112845","volume":"21","author":"VV Kleandrova","year":"2021","unstructured":"Kleandrova VV, Scotti MT, Scotti L, Speck-Planche A. Multi-target drug discovery via PTML modeling: applications to the design of virtual dual inhibitors of CDK4 and HER2. Curr Top Med Chem. 2021;21:661\u201375.","journal-title":"Curr Top Med Chem"},{"key":"330_CR50","doi-asserted-by":"publisher","unstructured":"Kleandrova VV, Specklanche A. PTML modeling for pancreatic cancer research: in silico design of simultaneous multi-protein and multi-cell inhibitors. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10020491.","DOI":"10.3390\/biomedicines10020491"},{"key":"330_CR51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1021\/acscombsci.8b00090","volume":"20","author":"H Bediaga","year":"2018","unstructured":"Bediaga H, Arrasate S, Gonz\u00e1lez-D\u00edaz H. PTML combinatorial model of ChEMBL compounds assays for multiple types of cancer. ACS Comb Sci. 2018;20:621\u201332.","journal-title":"ACS Comb Sci"},{"key":"330_CR52","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1021\/acs.molpharmaceut.0c00308","volume":"17","author":"R Santana","year":"2020","unstructured":"Santana R, et al. PTML model for selection of nanoparticles, anticancer drugs, and vitamins in the design of drug-vitamin nanoparticle release systems for cancer cotherapy. Mol Pharm. 2020;17:2612\u201327.","journal-title":"Mol Pharm"},{"key":"330_CR53","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/acs.jcim.3c01796","volume":"64","author":"Y Vel\u00e1squez-L\u00f3pez","year":"2024","unstructured":"Vel\u00e1squez-L\u00f3pez Y, Ruiz-Escudero A, Arrasate S, Gonz\u00e1lez-D\u00edaz H. Implementation of IFPTML computational models in drug discovery against flaviviridae family. J Chem Inf Model. 2024;64:1841\u201352.","journal-title":"J Chem Inf Model"},{"key":"330_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/ph18020196","volume":"18","author":"VV Kleandrova","year":"2025","unstructured":"Kleandrova VV, Cordeiro MNDS, Speck-Planche A. In silico approach for antibacterial discovery: PTML modeling of virtual multi-strain inhibitors against Staphylococcus aureus. Pharmaceuticals. 2025;18:196.","journal-title":"Pharmaceuticals"},{"key":"330_CR55","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1021\/acs.jcim.9b00034","volume":"59","author":"D Nocedo-Mena","year":"2019","unstructured":"Nocedo-Mena D, et al. Modeling antibacterial activity with machine learning and fusion of chemical structure information with microorganism metabolic networks. J Chem Inf Model. 2019;59:1109\u201320.","journal-title":"J Chem Inf Model"},{"key":"330_CR56","doi-asserted-by":"publisher","first-page":"32119","DOI":"10.1021\/acsomega.2c03363","volume":"7","author":"A Speck-Planche","year":"2022","unstructured":"Speck-Planche A, Kleandrova VV. Multi-condition QSAR model for the virtual design of chemicals with dual pan-antiviral and anti-cytokine storm profiles. ACS Omega. 2022;7:32119\u201330.","journal-title":"ACS Omega"},{"key":"330_CR57","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1021\/acs.jcim.2c00731","volume":"62","author":"C Santiago","year":"2022","unstructured":"Santiago C, et al. Prediction of antileishmanial compounds: general model, preparation, and evaluation of 2-acylpyrrole derivatives. J Chem Inf Model. 2022;62:3928\u201340.","journal-title":"J Chem Inf Model"},{"key":"330_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116602","volume":"174","author":"M Baltasar-Marchueta","year":"2024","unstructured":"Baltasar-Marchueta M, et al. Identification of Riluzole derivatives as novel calmodulin inhibitors with neuroprotective activity by a joint synthesis, biosensor, and computational guided strategy. Biomed Pharmacother. 2024;174: 116602.","journal-title":"Biomed Pharmacother"},{"key":"330_CR59","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1021\/acschemneuro.0c00687","volume":"12","author":"IE Sampaio-Dias","year":"2021","unstructured":"Sampaio-Dias IE, et al. Synthesis, pharmacological, and biological evaluation of 2-furoyl-based MIF-1 peptidomimetics and the development of a general-purpose model for allosteric modulators (ALLOPTML). ACS Chem Neurosci. 2021;12:203\u201315.","journal-title":"ACS Chem Neurosci"},{"key":"330_CR60","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1021\/acs.jproteome.6b00618","volume":"16","author":"M Wen","year":"2017","unstructured":"Wen M, et al. Deep-learning-based drug-target interaction prediction. J Proteome Res. 2017;16:1401\u20139.","journal-title":"J Proteome Res"},{"key":"330_CR61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12967-023-03876-3","volume":"21","author":"Z-H Ren","year":"2023","unstructured":"Ren Z-H, et al. DeepMPF: deep learning framework for predicting drug\u2013target interactions based on multi-modal representation with meta-path semantic analysis. J Transl Med. 2023;21:48.","journal-title":"J Transl Med"},{"key":"330_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007129","volume":"15","author":"I Lee","year":"2019","unstructured":"Lee I, Keum J, Nam H. DeepConv-DTI: prediction of drug-target interactions via deep learning with convolution on protein sequences. PLOS Comput Biol. 2019;15: e1007129.","journal-title":"PLOS Comput Biol"},{"key":"330_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2020.113978","volume":"610","author":"SM Hasan Mahmud","year":"2020","unstructured":"Hasan Mahmud SM, et al. DeepACTION: a deep learning-based method for predicting novel drug-target interactions. Anal Biochem. 2020;610: 113978.","journal-title":"Anal Biochem"},{"key":"330_CR64","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1080\/07391102.2014.998710","volume":"33","author":"X Xiao","year":"2015","unstructured":"Xiao X, et al. iDrug-Target: predicting the interactions between drug compounds and target proteins in cellular networking via benchmark dataset optimization approach. J Biomol Struct Dyn. 2015;33:2221\u201333.","journal-title":"J Biomol Struct Dyn"},{"key":"330_CR65","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1093\/bioinformatics\/btz519","volume":"35","author":"Z Li","year":"2019","unstructured":"Li Z, et al. KinomeX: a web application for predicting kinome-wide polypharmacology effect of small molecules. Bioinformatics. 2019;35:5354\u20136.","journal-title":"Bioinformatics"},{"key":"330_CR66","unstructured":"Cyclica Launches Ligand ExpressTM, a disruptive cloud-based platform to revolutionize drug discovery | Business Wire. https:\/\/www.businesswire.com\/news\/home\/20171130005015\/en\/Cyclica-Launches-Ligand-Express%E2%84%A2-a-Disruptive-Cloud-Based-Platform-to-Revolutionize-Drug-Discovery."},{"key":"330_CR67","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.chempr.2018.02.024","volume":"4","author":"BA Grzybowski","year":"2018","unstructured":"Grzybowski BA, et al. Chematica: a story of computer code that started to think like a chemist. Chem. 2018;4:390\u20138.","journal-title":"Chem"},{"key":"330_CR68","doi-asserted-by":"publisher","unstructured":"Sanchez-Lengeling B, Outeiral C, Guimaraes GL, Aspuru-Guzik A. Optimizing distributions over molecular space. An objective-reinforced generative adversarial network for inverse-design chemistry (ORGANIC). 2017. https:\/\/doi.org\/10.26434\/chemrxiv.5309668.v2.","DOI":"10.26434\/chemrxiv.5309668.v2"},{"key":"330_CR69","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1021\/acs.jcim.7b00690","volume":"58","author":"E Putin","year":"2018","unstructured":"Putin E, et al. Reinforced adversarial neural computer for de novo molecular design. J Chem Inf Model. 2018;58:1194\u2013204.","journal-title":"J Chem Inf Model"},{"key":"330_CR70","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/acscentsci.7b00512","volume":"4","author":"MHS Segler","year":"2018","unstructured":"Segler MHS, Kogej T, Tyrchan C, Waller MP. Generating focused molecule libraries for drug discovery with recurrent neural networks. ACS Cent Sci. 2018;4:120\u201331.","journal-title":"ACS Cent Sci"},{"key":"330_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108810","volume":"179","author":"S Singh","year":"2024","unstructured":"Singh S, Kaur N, Gehlot A. Application of artificial intelligence in drug design: a review. Comput Biol Med. 2024;179: 108810.","journal-title":"Comput Biol Med"},{"key":"330_CR72","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/ph16091259","volume":"16","author":"R Han","year":"2023","unstructured":"Han R, Yoon H, Kim G, Lee H, Lee Y. Revolutionizing medicinal chemistry: the application of artificial intelligence (AI) in early drug discovery. Pharmaceuticals. 2023;16:1259.","journal-title":"Pharmaceuticals"},{"key":"330_CR73","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s11030-021-10256-w","volume":"25","author":"MK Tripathi","year":"2021","unstructured":"Tripathi MK, Nath A, Singh TP, Ethayathulla AS, Kaur P. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery. Mol Divers. 2021;25:1439\u201360.","journal-title":"Mol Divers"},{"key":"330_CR74","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/life14020233","volume":"14","author":"AI Visan","year":"2024","unstructured":"Visan AI, Negut I. Integrating artificial intelligence for drug discovery in the context of revolutionizing drug delivery. Life. 2024;14:233.","journal-title":"Life"},{"key":"330_CR75","doi-asserted-by":"crossref","unstructured":"The Atomwise AIMS Program et al. AI is a viable alternative to high throughput screening: a 318-target study. Sci Rep. 2024;14: 7526.","DOI":"10.1038\/s41598-024-54655-z"},{"key":"330_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2023.100038","volume":"2","author":"S Bechelli","year":"2024","unstructured":"Bechelli S, Delhommelle J. AI\u2019s role in pharmaceuticals: assisting drug design from protein interactions to drug development. Artif Intell Chem. 2024;2: 100038.","journal-title":"Artif Intell Chem"},{"key":"330_CR77","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.2174\/0929867327666200526142958","volume":"28","author":"W Shan","year":"2021","unstructured":"Shan W, Li X, Yao H, Lin K. Convolutional neural network-based virtual screening. Curr Med Chem. 2021;28:2033\u201347.","journal-title":"Curr Med Chem"},{"key":"330_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.aiopen.2021.01.001","volume":"1","author":"J Zhou","year":"2020","unstructured":"Zhou J, et al. Graph neural networks: a review of methods and applications. AI Open. 2020;1:57\u201381.","journal-title":"AI Open"},{"key":"330_CR79","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1021\/acs.jcim.2c01422","volume":"62","author":"TA Soares","year":"2022","unstructured":"Soares TA, et al. The (re)-evolution of quantitative structure-activity relationship (QSAR) studies propelled by the surge of machine learning methods. J Chem Inf Model. 2022;62:5317\u201320.","journal-title":"J Chem Inf Model"},{"key":"330_CR80","doi-asserted-by":"publisher","first-page":"7761","DOI":"10.1038\/s41467-024-52061-7","volume":"15","author":"G Zhou","year":"2024","unstructured":"Zhou G, et al. An artificial intelligence accelerated virtual screening platform for drug discovery. Nat Commun. 2024;15:7761.","journal-title":"Nat Commun"},{"key":"330_CR81","doi-asserted-by":"crossref","unstructured":"Vilar S, Costanzi S. Predicting the biological activities through QSAR analysis and docking-based scoring. In: Vaidehi N, Klein-Seetharaman J, editors. Membrane protein structure and dynamics vol. 914. Humana Press, Totowa, NJ; 2012. Pp. 271\u2013284.","DOI":"10.1007\/978-1-62703-023-6_16"},{"key":"330_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-024-03253-9","author":"AA Fadahunsi","year":"2024","unstructured":"Fadahunsi AA, et al. Revolutionizing drug discovery: an AI-powered transformation of molecular docking. Med Chem Res. 2024. https:\/\/doi.org\/10.1007\/s00044-024-03253-9.","journal-title":"Med Chem Res"},{"key":"330_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101319","volume":"7","author":"A Sarkar","year":"2024","unstructured":"Sarkar A, Concilio S, Sessa L, Marrafino F, Piotto S. Advancements and novel approaches in modified AutoDock Vina algorithms for enhanced molecular docking. Results Chem. 2024;7: 101319.","journal-title":"Results Chem"},{"key":"330_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2023.100039","volume":"2","author":"S Singh","year":"2024","unstructured":"Singh S, Gupta H, Sharma P, Sahi S. Advances in Artificial Intelligence (AI)-assisted approaches in drug screening. Artif Intell Chem. 2024;2: 100039.","journal-title":"Artif Intell Chem"},{"key":"330_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17575","volume":"9","author":"R Qureshi","year":"2023","unstructured":"Qureshi R, et al. AI in drug discovery and its clinical relevance. Heliyon. 2023;9: e17575.","journal-title":"Heliyon"},{"key":"330_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2024.100070","volume":"2","author":"S Guan","year":"2024","unstructured":"Guan S, Wang G. Drug discovery and development in the era of artificial intelligence: from machine learning to large language models. Artif Intell Chem. 2024;2: 100070.","journal-title":"Artif Intell Chem"},{"key":"330_CR87","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.eng.2023.01.014","volume":"27","author":"M Lu","year":"2023","unstructured":"Lu M, et al. Artificial Intelligence in pharmaceutical sciences. Engineering. 2023;27:37\u201369.","journal-title":"Engineering"},{"key":"330_CR88","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1021\/acsmedchemlett.1c00662","volume":"13","author":"PB Cox","year":"2022","unstructured":"Cox PB, Gupta R. Contemporary computational applications and tools in drug discovery. ACS Med Chem Lett. 2022;13:1016\u201329.","journal-title":"ACS Med Chem Lett"},{"key":"330_CR89","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1134\/S1068162023020139","volume":"49","author":"VS Kulkarni","year":"2023","unstructured":"Kulkarni VS, Alagarsamy V, Solomon VR, Jose PA, Murugesan S. Drug repurposing: an effective tool in modern drug discovery. Russ J Bioorgan Chem. 2023;49:157\u201366.","journal-title":"Russ J Bioorgan Chem"},{"key":"330_CR90","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/v12091058","volume":"12","author":"ZY Low","year":"2020","unstructured":"Low ZY, Farouk IA, Lal SK. Drug repositioning: new approaches and future prospects for life-debilitating diseases and the COVID-19 pandemic outbreak. Viruses. 2020;12:1058.","journal-title":"Viruses"},{"key":"330_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2024.100071","volume":"2","author":"A Singh","year":"2024","unstructured":"Singh A. Artificial intelligence for drug repurposing against infectious diseases. Artif Intell Chem. 2024;2: 100071.","journal-title":"Artif Intell Chem"},{"key":"330_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202300816","volume":"25","author":"MKG Abbas","year":"2024","unstructured":"Abbas MKG, Rassam A, Karamshahi F, Abunora R, Abouseada M. The role of AI in drug discovery. ChemBioChem. 2024;25: e202300816.","journal-title":"ChemBioChem"},{"key":"330_CR93","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.burnso.2023.07.001","volume":"7","author":"N Foster","year":"2023","unstructured":"Foster N, et al. IBM Watson AI-enhanced search tool identifies novel candidate genes and provides insight into potential pathomechanisms of traumatic heterotopic ossification. Burns Open. 2023;7:126\u201338.","journal-title":"Burns Open"},{"key":"330_CR94","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13167-019-00196-9","volume":"11","author":"JS Berger","year":"2020","unstructured":"Berger JS, et al. Evaluation of machine learning methodology for the prediction of healthcare resource utilization and healthcare costs in patients with critical limb ischemia\u2014is preventive and personalized approach on the horizon? EPMA J. 2020;11:53\u201364.","journal-title":"EPMA J"},{"key":"330_CR95","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s13300-020-00759-4","volume":"11","author":"L Mueller","year":"2020","unstructured":"Mueller L, et al. Application of machine learning models to evaluate hypoglycemia risk in type 2 diabetes. Diabetes Ther. 2020;11:681\u201399.","journal-title":"Diabetes Ther"},{"key":"330_CR96","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S1474-4422(17)30328-9","volume":"16","author":"JC Latourelle","year":"2017","unstructured":"Latourelle JC, et al. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson\u2019s disease: a longitudinal cohort study and validation. Lancet Neurol. 2017;16:908\u201316.","journal-title":"Lancet Neurol"},{"key":"330_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.588221","volume":"10","author":"N Biswas","year":"2020","unstructured":"Biswas N, Chakrabarti S. Artificial Intelligence (AI)-based systems biology approaches in multi-omics data analysis of cancer. Front Oncol. 2020;10: 588221.","journal-title":"Front Oncol"},{"key":"330_CR98","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/bib\/bbw136","volume":"19","author":"K Shameer","year":"2018","unstructured":"Shameer K, et al. Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning. Brief Bioinform. 2018;19:656\u201378.","journal-title":"Brief Bioinform"},{"key":"330_CR99","doi-asserted-by":"publisher","first-page":"1393415","DOI":"10.3389\/fphar.2024.1393415","volume":"15","author":"R Yao","year":"2024","unstructured":"Yao R, et al. Knowledge mapping of graph neural networks for drug discovery: a bibliometric and visualized analysis. Front Pharmacol. 2024;15:1393415.","journal-title":"Front Pharmacol"},{"key":"330_CR100","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"330_CR101","doi-asserted-by":"publisher","first-page":"1120370","DOI":"10.3389\/fbinf.2023.1120370","volume":"3","author":"LMF Bertoline","year":"2023","unstructured":"Bertoline LMF, Lima AN, Krieger JE, Teixeira SK. Before and after AlphaFold2: an overview of protein structure prediction. Front Bioinforma. 2023;3:1120370.","journal-title":"Front Bioinforma"},{"key":"330_CR102","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493\u2013500.","journal-title":"Nature"},{"key":"330_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104052","volume":"25","author":"Y-W Chen","year":"2022","unstructured":"Chen Y-W, et al. PharmOmics: a species- and tissue-specific drug signature database and gene-network-based drug repositioning tool. IScience. 2022;25: 104052.","journal-title":"IScience"},{"key":"330_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.842641","volume":"9","author":"T Asano","year":"2022","unstructured":"Asano T, et al. In silico drug screening approach using L1000-based connectivity map and its application to COVID-19. Front Cardiovasc Med. 2022;9: 842641.","journal-title":"Front Cardiovasc Med"},{"key":"330_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.709856","volume":"12","author":"DP Smith","year":"2021","unstructured":"Smith DP, et al. Expert-augmented computational drug repurposing identified baricitinib as a treatment for COVID-19. Front Pharmacol. 2021;12: 709856.","journal-title":"Front Pharmacol"},{"key":"330_CR106","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.slasd.2023.08.009","volume":"28","author":"GP Way","year":"2023","unstructured":"Way GP, Sailem H, Shave S, Kasprowicz R, Carragher NO. Evolution and impact of high content imaging. SLAS Discov. 2023;28:292\u2013305.","journal-title":"SLAS Discov"},{"key":"330_CR107","doi-asserted-by":"publisher","first-page":"7772","DOI":"10.3390\/app11177772","volume":"11","author":"D Zhuang","year":"2021","unstructured":"Zhuang D, Ibrahim AK. Deep learning for drug discovery: a study of identifying high efficacy drug compounds using a cascade transfer learning approach. Appl Sci. 2021;11:7772.","journal-title":"Appl Sci"},{"key":"330_CR108","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.xphs.2016.09.022","volume":"106","author":"M Landin","year":"2017","unstructured":"Landin M. Artificial intelligence tools for scaling up of high shear wet granulation process. J Pharm Sci. 2017;106:273\u20137.","journal-title":"J Pharm Sci"},{"key":"330_CR109","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12911-024-02485-4","volume":"24","author":"M Momeni","year":"2024","unstructured":"Momeni M, Afkanpour M, Rakhshani S, Mehrabian A, Tabesh H. A prediction model based on artificial intelligence techniques for disintegration time and hardness of fast disintegrating tablets in pre-formulation tests. BMC Med Inform Decis Mak. 2024;24:88.","journal-title":"BMC Med Inform Decis Mak"},{"key":"330_CR110","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41467-022-35343-w","volume":"14","author":"P Bannigan","year":"2023","unstructured":"Bannigan P, et al. Machine learning models to accelerate the design of polymeric long-acting injectables. Nat Commun. 2023;14:35.","journal-title":"Nat Commun"},{"key":"330_CR111","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cherd.2020.12.010","volume":"166","author":"S Unnikrishnan","year":"2021","unstructured":"Unnikrishnan S, Donovan J, Macpherson R, Tormey D. In-process analysis of pharmaceutical emulsions using computer vision and artificial intelligence. Chem Eng Res Des. 2021;166:281\u201394.","journal-title":"Chem Eng Res Des"},{"key":"330_CR112","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/pharmaceutics12090877","volume":"12","author":"C Hirschberg","year":"2020","unstructured":"Hirschberg C, Edinger M, Holmfred E, Rantanen J, Boetker J. Image-based artificial intelligence methods for product control of tablet coating quality. Pharmaceutics. 2020;12:877.","journal-title":"Pharmaceutics"},{"key":"330_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2024.102061","volume":"36","author":"M Elbadawi","year":"2024","unstructured":"Elbadawi M, et al. Artificial intelligence generates novel 3D printing formulations. Appl Mater Today. 2024;36: 102061.","journal-title":"Appl Mater Today"},{"key":"330_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123060","volume":"641","author":"L Madar\u00e1sz","year":"2023","unstructured":"Madar\u00e1sz L, M\u00e9sz\u00e1ros LA, K\u00f6te \u00c1, Farkas A, Nagy ZK. AI-based analysis of in-line process endoscope images for real-time particle size measurement in a continuous pharmaceutical milling process. Int J Pharm. 2023;641: 123060.","journal-title":"Int J Pharm"},{"key":"330_CR115","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0168-3659(97)00030-8","volume":"49","author":"J Takahara","year":"1997","unstructured":"Takahara J, Takayama K, Nagai T. Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations. J Controlled Release. 1997;49:11\u201320.","journal-title":"J Controlled Release"},{"key":"330_CR116","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s005210200003","volume":"10","author":"WY Goh","year":"2002","unstructured":"Goh WY, Lim CP, Peh KK, Subari K. Application of a recurrent neural network to prediction of drug dissolution profiles. Neural Comput Appl. 2002;10:311\u20137.","journal-title":"Neural Comput Appl"},{"key":"330_CR117","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0168-3659(98)00171-0","volume":"59","author":"Y Chen","year":"1999","unstructured":"Chen Y, McCall TW, Baichwal AR, Meyer MC. The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. J Controlled Release. 1999;59:33\u201341.","journal-title":"J Controlled Release"},{"key":"330_CR118","first-page":"20","volume":"5","author":"T Patel","year":"2015","unstructured":"Patel T, Patel L, Patel T, Suhagia D. Artificial neural network as tool for quality by design in formulation development of solid dispersion of fenofibrate. Bull Pharm Res. 2015;5:20\u20137.","journal-title":"Bull Pharm Res"},{"key":"330_CR119","first-page":"1","volume":"12","author":"L Zhang","year":"2017","unstructured":"Zhang L, Mao S. Application of quality by design in the current drug development. Asian J Pharm Sci. 2017;12:1\u20138.","journal-title":"Asian J Pharm Sci"},{"key":"330_CR120","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1208\/s12249-014-0174-z","volume":"15","author":"M Gams","year":"2014","unstructured":"Gams M, Horvat M, O\u017eek M, Lu\u0161trek M, Gradi\u0161ek A. Integrating artificial and human intelligence into tablet production process. AAPS PharmSciTech. 2014;15:1447\u201353.","journal-title":"AAPS PharmSciTech"},{"key":"330_CR121","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/07373937.2012.718308","volume":"31","author":"EN Dr\u0103goi","year":"2013","unstructured":"Dr\u0103goi EN, Curteanu S, Fissore D. On the use of artificial neural networks to monitor a pharmaceutical freeze-drying process. Dry Technol. 2013;31:72\u201381.","journal-title":"Dry Technol"},{"key":"330_CR122","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF02784878","volume":"1","author":"C Zhao","year":"2006","unstructured":"Zhao C, et al. Toward intelligent decision support for pharmaceutical product development. J Pharm Innov. 2006;1:23\u201335.","journal-title":"J Pharm Innov"},{"key":"330_CR123","doi-asserted-by":"publisher","unstructured":"Wang X. Intelligent quality management using knowledge discovery in databases. In 2009 International Conference on Computational Intelligence and Software Engineering, IEEE, Wuhan, China; 2009. 1\u20134 https:\/\/doi.org\/10.1109\/CISE.2009.5364999.","DOI":"10.1109\/CISE.2009.5364999"},{"key":"330_CR124","first-page":"4211","volume":"109","author":"H Chopra","year":"2023","unstructured":"Chopra H, et al. Revolutionizing clinical trials: the role of AI in accelerating medical breakthroughs. Int J Surg. 2023;109:4211\u201320.","journal-title":"Int J Surg"},{"key":"330_CR125","unstructured":"Leading Clinical Trials AI Software\u2014Deep6 AI. Deep6.ai https:\/\/deep6.ai\/."},{"key":"330_CR126","unstructured":"Antidote. Clinical Trial Patient Recruitment | Antidote. https:\/\/www.antidote.me."},{"key":"330_CR127","unstructured":"Trials.ai\u2014Our Smart Protocol technology helps teams design better clinical trials with AI. https:\/\/trials.ai\/."},{"key":"330_CR128","unstructured":"AI Healthcare Solutions & Advanced Analytics | Medidata AI. Medidata Solutions. https:\/\/www.medidata.com\/en\/clinical-trial-products\/medidata-ai\/."},{"key":"330_CR129","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/jamiaopen\/ooaa002","volume":"3","author":"M Alexander","year":"2020","unstructured":"Alexander M, et al. Evaluation of an artificial intelligence clinical trial matching system in Australian lung cancer patients. JAMIA Open. 2020;3:209\u201315.","journal-title":"JAMIA Open"},{"key":"330_CR130","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1016\/j.jclinepi.2013.02.015","volume":"66","author":"JT Connor","year":"2013","unstructured":"Connor JT, Elm JJ, Broglio KR. Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. J Clin Epidemiol. 2013;66:S130\u20137.","journal-title":"J Clin Epidemiol"},{"key":"330_CR131","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12874-024-02235-0","volume":"24","author":"SY Lee","year":"2024","unstructured":"Lee SY. Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review. BMC Med Res Methodol. 2024;24:110.","journal-title":"BMC Med Res Methodol"},{"key":"330_CR132","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1517\/17425250802691074","volume":"5","author":"M Jamei","year":"2009","unstructured":"Jamei M, et al. The Simcyp \u00ae population-based ADME simulator. Expert Opin Drug Metab Toxicol. 2009;5:211\u201323.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"330_CR133","unstructured":"Clinical Trial Management Platform with Patient-Level AI. AiCure https:\/\/aicure.com\/."},{"key":"330_CR134","unstructured":"Verily | Health Data Orchestration Platform and AI | Alphabet Precision Health. https:\/\/verily.com\/home."},{"key":"330_CR135","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.tips.2019.07.005","volume":"40","author":"AO Basile","year":"2019","unstructured":"Basile AO, Yahi A, Tatonetti NP. Artificial intelligence for drug toxicity and safety. Trends Pharmacol Sci. 2019;40:624\u201335.","journal-title":"Trends Pharmacol Sci"},{"key":"330_CR136","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1039\/D3SC05534E","volume":"15","author":"K Martinez-Mayorga","year":"2024","unstructured":"Martinez-Mayorga K, et al. The pursuit of accurate predictive models of the bioactivity of small molecules. Chem Sci. 2024;15:1938\u201352.","journal-title":"Chem Sci"},{"key":"330_CR137","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","volume":"31","author":"K Zhang","year":"2025","unstructured":"Zhang K, et al. Artificial intelligence in drug development. Nat Med. 2025;31:45\u201359.","journal-title":"Nat Med"}],"container-title":["Discover Artificial Intelligence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44163-025-00330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44163-025-00330-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44163-025-00330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T14:01:48Z","timestamp":1748181708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44163-025-00330-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["330"],"URL":"https:\/\/doi.org\/10.1007\/s44163-025-00330-9","relation":{},"ISSN":["2731-0809"],"issn-type":[{"value":"2731-0809","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}